TCL Archive Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease By Cancer History Project February 22, 2013
TCL Archive Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard By Cancer History Project February 22, 2013
TCL Archive Avastin Increases Overall Survival 3.7 Months By Cancer History Project February 22, 2013
TCL Archive First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma By Cancer History Project February 22, 2013
TCL Archive Phase III Trial of ThermoDox Fails to Meet Primary Endpoint By Cancer History Project February 22, 2013
TCL Archive Neulasta Reduces Incidence Of Febrile Neutropenia By Cancer History Project February 22, 2013
TCL Archive Tivozanib Does Not Improve OS Compared to Sorafenib By Cancer History Project February 22, 2013
Primary SourceSpotlight Article Iressa: Oncologic Drugs Advisory Committee Meeting Sept. 24, 2002 By FDA Oncology Center of Excellence
Primary SourceSpotlight Article Waun Ki Hong, M.D. Oral History Interview, 2013 By MD Anderson Cancer Center